Home > Balance Sheet > CIPLA

CIPLA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
CIPLA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CIPLA
Please provide your vote to see the results

CIPLA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Deferred Tax Assets / Liabilities ₹-403 Cr₹-293 Cr₹-205 Cr₹-18 Cr₹125 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of CIPLA ?

The latest Deferred Tax Assets / Liabilities ratio of CIPLA is ₹-403 Cr based on Mar2024 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2024₹-403 Cr
Mar2023₹-293 Cr
Mar2022₹-205 Cr
Mar2021₹-18 Cr
Mar2020₹125 Cr

How is Deferred Tax Assets / Liabilities of CIPLA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2024 ₹-403 Cr
Negative
Mar2023 ₹-293 Cr
Negative
Mar2022 ₹-205 Cr
Negative
Mar2021 ₹-18 Cr
Negative
Mar2020 ₹125 Cr -

Compare Deferred Tax Assets / Liabilities of peers of CIPLA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CIPLA ₹123,327.7 Cr 1.1% 1.8% -1.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,420.0 Cr -0.2% -2.9% 12.6% Stock Analytics
DIVIS LABORATORIES ₹177,572.0 Cr 0.3% 6.5% 49% Stock Analytics
DR REDDYS LABORATORIES ₹112,396.0 Cr -0.2% 9.5% 12.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,956.0 Cr 1.9% 0.4% 14% Stock Analytics
MANKIND PHARMA ₹97,734.2 Cr -0.4% -7.8% 9.9% Stock Analytics


CIPLA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CIPLA

1.1%

1.8%

-1.6%

SENSEX

-0.8%

-0.9%

6.9%


You may also like the below Video Courses